IgA antibodies in the gut have been demonstrated to moderate deleterious host responses to fluctuations in the microbiome and mucosal IgA deficiency leads to aberrant systemic exposures and immune responses to commensal bacteria (56, 77). Here, CD79A is linked to hyperinsulinemic hypoglycemia, familial, 4.